Gianluca Quintini

Gianluca Quintini serves as the Senior Director of Biomarker Development and Translational Science at CureVac AG since September 2018, following a role as Associate Director of Applied Clinical Biology at Dr. Reddy's Laboratories where responsibilities included clinical development of biosimilars. Previous roles include Senior Medical Research Scientist at Protagen AG, Principal Scientist for Biomarkers at Takeda, and Biomarker Specialist at Nycomed GmbH, among others. With a solid educational foundation including a PhD in Biology from the University of Konstanz and a Laurea from the University of Milan, Gianluca has extensive experience in biomarker strategies, clinical trials, and translational medicine across various therapeutic areas.